Recent advances in the molecular imaging of programmed cell death: Part II - Non-probe-based MRI, ultrasound, and optical clinical imaging techniques

Journal of Nuclear Medicine

Volumn 54, Issue 1, 2013, Pages 1-4

  Blankenberg, Francis G ^a   Strauss, H William ^b  

^a LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Apoptosis; MRI; MRS; Necrosis; Optical imaging; Ultrasound

Indexed keywords

CELL MARKER; CHOLINE; LIPID; TRACER;

APOPTOSIS; CANCER THERAPY; CELL METABOLISM; CYTOPLASM; DIFFUSION WEIGHTED IMAGING; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; IMAGING SYSTEM; IN VIVO STUDY; INFRARED SPECTROSCOPY; MOLECULAR IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SIGNAL NOISE RATIO; SIGNAL TRANSDUCTION; SOLID TUMOR; ULTRASOUND;

ANIMALS; APOPTOSIS; HUMANS; MAGNETIC RESONANCE IMAGING; MOLECULAR IMAGING; NEOPLASMS; OPTICAL IMAGING; ULTRASONOGRAPHY;

EID: 84872035200     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.112.111740     Document Type: Review

References (38)

1. Blankenberg FG, Strauss HW. Recent advances in the molecular imaging of programmed cell death: part I - pathophysiology and radiotracers. J Nucl Med. 2012;53:1659-1662.
2. 1H magnetic resonance spectroscopy and imaging. NMR Biomed. 2010;23:624-632.
3. Delikatny EJ, Chawla S, Leung DJ, Poptani H. MR-visible lipids and the tumor microenvironment. NMR Biomed. 2011;24:592-611.
4. Zietkowski D, Payne GS, Nagy E, Mobberley MA, Ryder TA, deSouza NM. Comparison of NMR lipid profiles in mitotic arrest and apoptosis as indicators of paclitaxel resistance in cervical cell lines. Magn Reson Med. 2012;68:369-377.
5. Liimatainen T, Hakumaki JM, Kauppinen RA, Ala-Korpela M. Monitoring of gliomas in vivo by diffusion MRI and 1H MRS during gene therapy-induced apoptosis: interrelationships between water diffusion and mobile lipids. NMR Biomed. 2009;22:272-279.
6. 1H NMR detection of mobile lipids as a marker for apoptosis: the case of anticancer drug-loaded liposomes and polymeric micelles. Mol Pharm. 2009;6:1876-1882.
7. 1H MR spectroscopy predicts apoptosis in cervical carcinomas. BMC Cancer. 2007;7:11.
8. 1H magnetic resonance spectroscopic imaging study with ex vivo correlation. Eur Radiol. 2009;19:2041-2048.
9. Le HC, Lupu M, Kotedia K, Rosen N, Solit D, Koutcher JA. Proton MRS detects metabolic changes in hormone sensitive and resistant human prostate cancer models CWR22 and CWR22r. Magn Reson Med. 2009;62:1112-1119.
10. Lindskog M. Proton magnetic resonance spectroscopy in neuroblastoma: current status, prospects and limitations. Cancer Lett. 2005;228:247-255. (Pubitemid 41188448)
11. Clemens MJ, Bushel M, Jeffrey IW, Pain VM, Morley SJ. Translation initiation factor modifications and the regulation of protein synthesis in apoptotic cells. Cell Death Differ. 2000;7:603-615. (Pubitemid 30456166)
12. Morley SJ, Coldwell MJ, Clemens MJ. Initiation factor modifications in the preapoptotic phase. Cell Death Differ. 2005;12:571-584. (Pubitemid 40774768)
13. 1H MRS in the assessment of the therapeutic response of breast cancer patients. NMR Biomed. 2011;24:700-711.
14. Bonekamp S, Shen J, Salibi N, Lai HC, Geschwind J, Kamel IR. Early response of hepatic malignancies to locoregional therapy: value of diffusion-weighted magnetic resonance imaging and proton magnetic resonance spectroscopy. J Comput Assist Tomogr. 2011;35:167-173.
15. Hsieh T-J, Li CW, Chuang HY, Liu GC, Wang CK. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience. J Comput Assist Tomogr. 2008;32:987-994.
16. 18F]-fluorodeoxyglucose positron emission tomography. J Magn Reson Imaging. 2008;28:420-427.
17. 1H magnetic resonance spectroscopy with diffusion magnetic resonance imaging. Jpn J Radiol. 2010;28:101-109.
18. 1H MR spectroscopy using the external standard method. J Magn Reson Imaging. 2010;31:895-902.
19. 1H MRS. NMR Biomed. 2010;23:56-65.
20. Huuse EM, Jensen LR, Goa PE, et al. Monitoring the effect of docetaxel treatment in MCF7 xenografts using multimodal in vivo and ex vivo magnetic resonance methods, histopathology, and gene expression. Transl Oncol. 2010;3:252-263.
21. Podo F, Canevari S, Canese R, Pisanu ME, Ricci A, Iorio E. MR evaluation of response to targeted treatment in cancer cells. NMR Biomed. 2011;24:648-672.
22. 1H-MR spectroscopy of choline and USPIO particles targeted at cell death. NMR Biomed. 2012;25:514-522.
23. Wybranski C, Zeilxe M, Löwenthal D, et al. Value of diffusion weighted MR imaging as an early surrogate parameter for evaluation of tumor response to high-dose-rate brachytherapy of colorectal liver metastases. Radiat Oncol. 2011;6:43.
24. Dudeck O, Zeile M, Wybranski C, et al. Early prediction of anticancer effects with diffusion-weighted MR imaging in patients with colorectal liver metastases following selective internal radiotherapy. Eur Radiol. 2010;20:2699-2706.
25. Padhani AR, Liu G, Koh DM, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia. 2009;11:102-125.
26. Rozel S, Galbán CJ, Nicolay K, et al. Synergy between anti-CCL2 and docetaxel as determined by DW-MRI in a metastatic bone cancer model. J Cell Biochem. 2009;107:58-64.
27. Huang MQ, Pickup S, Nelson DS, et al. Monitoring response to chemotherapy of non-Hodgkin's lymphoma xenografts by T2-weighted and diffusion-weighted MRI. NMR Biomed. 2008;21:1021-1029.
28. Kim H, Morgan DE, Zeng H, et al. Breast tumor xenografts: diffusion-weighted MR imaging to assess early therapy with novel apoptosis-inducing anti-DR5 antibody. Radiology. 2008;248:844-851.
29. Vlad RM, Kolios MC, Moseley JL, Czarnota GJ, Brock KK. Evaluating the extent of cell death in 3D high frequency ultrasound by registration with whole-mount tumor histopathology. Med Phys. 2010;37:4288-4297.
30. Banihashemi B, et al. Ultrasound imaging of apoptosis in tumor response: novel preclinical monitoring of photodynamic therapy effects. Cancer Res. 2008;68:8590-8596.
31. Vlad RM, Alajez NM, Giles A, Kolios MC, Czarnota GJ. Quantitative ultrasound characterization of cancer radiotherapy effects in vitro. Int J Radiat Oncol Biol Phys. 2008;72:1236-1243.
32. Vlad RM, Kolios MC, Czarnota GJ. Ultrasound imaging of apoptosis: spectroscopic detection of DNA-damage effects at high and low frequencies. Methods Mol Biol. 2011;682:165-187.
33. Farhat G, et al. Detecting cell death with optical coherence tomography and envelope statistics. J Biomed Opt. 2011;16:026017.
34. Strohm E, Czarnota GJ, Kolios MC. Quantitative measurements of apoptotic cell properties using acoustic microscopy. IEEE Trans Ultrason Ferroelectr Freq Control. 2010;57:2293-2304.
35. Holman HY, Martin MC, Blakely EA, Bjornstad K, McKinney WR. IR spectroscopic characteristics of cell cycle and cell death probed by synchrotron radiation based Fourier transform IR spectromicroscopy. Biopolymers. 2000; 57:329-335.
36. Holman HY, Bechtel HA, Hao Z, Martin MC, Synchrotron IR. Spectromicroscopy: chemistry of living cells. Anal Chem. 2010;82:8757-8765.
37. Chen L, Holman HY, Hao Z, et al. Synchrotron infrared measurements of protein phosphorylation in living single PC12 cells during neuronal differentiation. Anal Chem. 2012;84:4118-4125.
38. Holman HY, Bjornstad KA, Martin MC, McKinney WR, Blakely EA, Blankenberg FG. Mid-infrared reflectivity of experimental atheromas. J Biomed Opt. 2008;13:030503.